- Home
- AVBH vs CGC Comparison
AVBH vs CGC Comparison
Compare AVBH & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AVBH | CGC |
|---|---|---|
| Founded | 2003 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | | Pharmaceuticals and Biotechnology |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 350.6M | 389.2M |
| IPO Year | 2025 | 2023 |
Fundamental Metrics
Financial Performance| Metric | AVBH | CGC |
|---|---|---|
| Price | $30.94 | $0.88 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $38.80 | $1.82 |
| AVG Volume (30 Days) | 51.3K | ★ 1.8M |
| Earning Date | 10-22-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 84.17 |
| EPS | ★ 1.55 | N/A |
| Revenue | N/A | ★ $12,759,000.00 |
| Revenue This Year | $24.18 | $21.39 |
| Revenue Next Year | $10.55 | $8.33 |
| P/E Ratio | $20.16 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $24.03 | $0.84 |
| 52 Week High | $34.18 | $2.38 |
Technical Indicators
Market Signals| Indicator | AVBH | CGC |
|---|---|---|
| Relative Strength Index (RSI) | 38.53 | 37.93 |
| Support Level | $30.18 | $0.85 |
| Resistance Level | $31.10 | $0.98 |
| Average True Range (ATR) | 0.46 | 0.03 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 10.26 | 16.31 |
Price Performance
Historical ComparisonAbout AVBH Avidbank Holdings Inc.
Avidbank Holdings Inc is a full-service commercial bank. It offers various services such as commercial and industrial lending, venture lending, structured finance, asset-based lending, sponsor finance, real estate construction, and commercial real estate lending.
About CGC Canopy Growth Corporation
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.